Brief: Lansen Pharmaceutical Holdings Posts FY Profit Attributable Of $15.6 Million
27/03/2018 12:13
March 27 (Reuters) - Lansen Pharmaceutical Holdings Ltd
0503.HK :
* FY REVENUE $89.5 MILLION, DOWN 5.6%
* DECLARES FINAL DIVIDEND OF HK3.58 CENTS PER SHARE
* FY PROFIT ATTRIBUTABLE $15.6 MILLION VERSUS $3.8 MILLION
Source text for Eikon: ID:nHKSjxMbL
Further company coverage: 0503.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lansen Pharmaceutical Holdings
See all newsBrief: Lansen Pharmaceutical Says Stock Exchange Approved Withdrawal Of Listing Of Shares From 9 AM, 19 Dec
Brief: Lansen Pharmaceutical Updates Withdrawal Of Listing Of Shares On Stock Exchange
Brief: Lansen Pharmaceutical Says Trading In Shares Will Be Halted
Brief: Lansen Pharmaceutical Posts FY Revenue Of $65.6 Mln VS $54.2 Mln
Brief: Lansen Pharmaceutical Sees Net Profit Attributable Of Approximately $8.1 Million For Year